Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Jin Medical International Ltd. (ZJYL)

Compare
0.6503
-0.0925
(-12.45%)
At close: April 2 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
23,502.0100
23,502.0100
19,821.4570
19,190.5410
20,764.2730
Cost of Revenue
13,999.2410
13,999.2410
13,036.6230
12,992.0230
14,403.1370
Gross Profit
9,502.7690
9,502.7690
6,784.8340
6,198.5180
6,361.1360
Operating Expense
5,864.0210
5,864.0210
3,917.5720
4,067.9940
3,729.6340
Operating Income
3,638.7480
3,638.7480
2,867.2620
2,130.5240
2,631.5020
Net Non Operating Interest Income Expense
466.5240
466.5240
182.6820
181.6050
-9.4920
Other Income Expense
78.4420
78.4420
171.9930
430.5090
258.3370
Pretax Income
4,183.7140
4,183.7140
3,221.9370
2,742.6380
2,880.3470
Tax Provision
763.8790
763.8790
343.7070
36.1110
248.6410
Net Income Common Stockholders
3,675.9270
3,675.9270
2,878.2300
2,706.5270
2,631.7060
Diluted NI Available to Com Stockholders
3,675.9270
3,675.9270
2,878.2300
2,706.5270
2,631.7060
Basic EPS
0.02
--
0.02
0.02
0.02
Diluted EPS
0.02
--
0.02
0.02
0.02
Basic Average Shares
156,474.1490
--
145,136.9800
150,000
155,000
Diluted Average Shares
156,474.1490
--
145,136.9800
150,000
155,000
Total Operating Income as Reported
3,638.7480
3,638.7480
2,867.2620
2,130.5240
2,631.5020
Total Expenses
19,863.2620
19,863.2620
16,954.1950
17,060.0170
18,132.7710
Net Income from Continuing & Discontinued Operation
3,675.9270
3,675.9270
2,878.2300
2,706.5270
2,631.7060
Normalized Income
3,697.8014
3,697.8014
2,923.2426
2,522.5561
2,573.7995
Interest Income
466.5240
466.5240
182.6820
181.6050
--
Interest Expense
--
--
--
--
9.4920
Net Interest Income
466.5240
466.5240
182.6820
181.6050
-9.4920
EBIT
3,638.7480
3,638.7480
2,867.2620
2,130.5240
2,631.5020
EBITDA
3,984.8800
3,984.8800
3,093.1640
2,493.1210
2,978.1100
Reconciled Cost of Revenue
13,999.2410
13,999.2410
13,036.6230
12,992.0230
14,403.1370
Reconciled Depreciation
346.1320
346.1320
225.9020
362.5970
346.6080
Net Income from Continuing Operation Net Minority Interest
3,675.9270
3,675.9270
2,878.2300
2,706.5270
2,631.7060
Total Unusual Items Excluding Goodwill
-26.7740
-26.7740
-50.4060
186.3940
63.3550
Total Unusual Items
-26.7740
-26.7740
-50.4060
186.3940
63.3550
Normalized EBITDA
4,011.6540
4,011.6540
3,143.5700
2,306.7270
2,914.7550
Tax Rate for Calcs
0.0002
0.0002
0.0001
0
0.0001
Tax Effect of Unusual Items
-4.8996
-4.8996
-5.3934
2.4231
5.4485
9/30/2021 - 3/28/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MLSS Milestone Scientific Inc.
0.9900
+4.21%
 
N3B.F Anbio Biotechnology
4.9435
0.00%
 
MEDIMI.ST Medimi AB (publ)
0.0018
-18.18%
 
ODIN.ST Odinwell AB
0.4980
+4.18%
 
S2M.ST S2Medical AB (publ)
0.0100
-4.76%
 
SDI.AX SDI Limited
0.8750
-2.23%
 
AVGR Avinger, Inc.
0.4740
-20.74%
 
EKSO Ekso Bionics Holdings, Inc.
0.4150
+2.32%
 
NEPH Nephros, Inc.
2.0300
+14.04%
 
NNNN Anbio Biotechnology Class A Ordinary Shares
7.00
-3.71%